State Street SPDR S&P Pharmaceuticals ETF (XPH) is a publicly traded the market company. As of August 4, 2026, XPH trades at $68.23 with a market cap of $0 and a P/E ratio of 0.00. XPH moved +0.25% today. Year to date, XPH is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces XPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for XPH, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $68.23 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 223.05K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
XPH analyst coverage data. Average price target: $0.00.